REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Endolink Pharma S.A. (Poland)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Secondary Activities: Medical Equipment and Supplies Manufacturing | Department Stores | Real Estate Property Managers | Office Machinery and Equipment Rental and Leasing | Administrative Management and General Management Consulting Services | Research and Development in Biotechnology (except Nanobiotechnology) | Office Administrative Services | All Other Support Services | Other Personal and Household Goods Repair and Maintenance
Full name: Endolink Pharma S.A. Profile Updated: December 03, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Endolink Pharma S.A. is an enterprise located in Poland, with the main office in Lodz. The enterprise operates in the Other Miscellaneous Nondurable Goods Merchant Wholesalers industry. The company was established on February 26, 2021. There was a net sales revenue increase of 3.99% reported in Endolink Pharma S.A.’s latest financial highlights for 2023. A growth of 4.44% was recorded in its total assets. The net profit margin of Endolink Pharma S.A. decreased by 6.3% in 2023.

Headquarters
Ul. Piotrkowska 46/8U
Lodz; Lodzkie; Postal Code: 90-265

Contact Details: Purchase the Endolink Pharma S.A. report to view the information.

Website: http://www.endolink.pl

Basic Information
Outstanding Shares:
Purchase the Endolink Pharma S.A. report to view the information.
Registered Capital:
Purchase the Endolink Pharma S.A. report to view the information.
Incorporation Date:
February 26, 2021
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Company Performance
Financial values in the chart are available after Endolink Pharma S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
3.99%▲
Total operating revenue
3.99%▲
Operating profit (EBIT)
2.62%▲
Net Profit (Loss) for the Period
-2.99%▼
Total assets
4.44%▲
Total equity
22.73%▲
Operating Profit Margin (ROS)
-1.28%▼
Net Profit Margin
-6.3%▼
Return on Equity (ROE)
-4.91%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo